My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 98

    1.

    Multiple pathways contribute to the pathogenesis of Huntington disease.

    Li S, Li XJ.

    Mol Neurodegener. 2006 Dec 16;1:19.PMID: 17173700 [PubMed]Related articlesFree article

    2.

    Accumulation of N-terminal mutant huntingtin in mouse and monkey models implicated as a pathogenic mechanism in Huntington's disease.

    Wang CE, Tydlacka S, Orr AL, Yang SH, Graham RK, Hayden MR, Li S, Chan AW, Li XJ.

    Hum Mol Genet. 2008 Sep 1;17(17):2738-51. Epub 2008 Jun 16.PMID: 18558632 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Mutant huntingtin in glial cells exacerbates neurological symptoms of Huntington disease mice.

    Bradford J, Shin JY, Roberts M, Wang CE, Sheng G, Li S, Li XJ.

    J Biol Chem. 2010 Feb 9. [Epub ahead of print]PMID: 20145253 [PubMed - as supplied by publisher]Related articlesFree article

    4.

    Huntingtin associated protein 1 and its functions.

    Wu LL, Zhou XF.

    Cell Adh Migr. 2009 Jan;3(1):71-6. Epub 2009 Jan 26.PMID: 19262167 [PubMed - in process]Related articlesFree article

    5.

    Selective degeneration in YAC mouse models of Huntington disease.

    Van Raamsdonk JM, Warby SC, Hayden MR.

    Brain Res Bull. 2007 Apr 30;72(2-3):124-31. Epub 2006 Nov 16. Review.PMID: 17352936 [PubMed - indexed for MEDLINE]Related articles

    6.

    N-terminal mutant huntingtin associates with mitochondria and impairs mitochondrial trafficking.

    Orr AL, Li S, Wang CE, Li H, Wang J, Rong J, Xu X, Mastroberardino PG, Greenamyre JT, Li XJ.

    J Neurosci. 2008 Mar 12;28(11):2783-92.PMID: 18337408 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Monoclonal antibodies recognize distinct conformational epitopes formed by polyglutamine in a mutant huntingtin fragment.

    Legleiter J, Lotz GP, Miller J, Ko J, Ng C, Williams GL, Finkbeiner S, Patterson PH, Muchowski PJ.

    J Biol Chem. 2009 Aug 7;284(32):21647-58. Epub 2009 Jun 2.PMID: 19491400 [PubMed - indexed for MEDLINE]Related articles

    9.

    Sex-dependent effect of BAG1 in ameliorating motor deficits of Huntington disease transgenic mice.

    Orr AL, Huang S, Roberts MA, Reed JC, Li S, Li XJ.

    J Biol Chem. 2008 Jun 6;283(23):16027-36. Epub 2008 Apr 8.PMID: 18400759 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Context-dependent dysregulation of transcription by mutant huntingtin.

    Cornett J, Smith L, Friedman M, Shin JY, Li XJ, Li SH.

    J Biol Chem. 2006 Nov 24;281(47):36198-204. Epub 2006 Sep 29.PMID: 17012230 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Huntingtin-deficient zebrafish exhibit defects in iron utilization and development.

    Lumsden AL, Henshall TL, Dayan S, Lardelli MT, Richards RI.

    Hum Mol Genet. 2007 Aug 15;16(16):1905-20. Epub 2007 Jun 13.PMID: 17567778 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.
    13.

    Mutant Huntingtin fragments form oligomers in a polyglutamine length-dependent manner in vitro and in vivo.

    Legleiter J, Mitchell E, Lotz GP, Sapp E, Ng C, Difiglia M, Thompson LM, Muchowski PJ.

    J Biol Chem. 2010 Mar 10. [Epub ahead of print]PMID: 20220138 [PubMed - as supplied by publisher]Related articlesFree article

    14.

    Towards a transgenic model of Huntington's disease in a non-human primate.

    Yang SH, Cheng PH, Banta H, Piotrowska-Nitsche K, Yang JJ, Cheng EC, Snyder B, Larkin K, Liu J, Orkin J, Fang ZH, Smith Y, Bachevalier J, Zola SM, Li SH, Li XJ, Chan AW.

    Nature. 2008 Jun 12;453(7197):921-4. Epub 2008 May 18.PMID: 18488016 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Full length mutant huntingtin is required for altered Ca2+ signaling and apoptosis of striatal neurons in the YAC mouse model of Huntington's disease.

    Zhang H, Li Q, Graham RK, Slow E, Hayden MR, Bezprozvanny I.

    Neurobiol Dis. 2008 Jul;31(1):80-8. Epub 2008 Apr 16.PMID: 18502655 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Inositol 1,4,5-tripshosphate receptor, calcium signalling and Huntington's disease.

    Bezprozvanny I.

    Subcell Biochem. 2007;45:323-35. Review.PMID: 18193642 [PubMed - indexed for MEDLINE]Related articles

    17.

    Inhibition of Rho kinases enhances the degradation of mutant huntingtin.

    Bauer PO, Wong HK, Oyama F, Goswami A, Okuno M, Kino Y, Miyazaki H, Nukina N.

    J Biol Chem. 2009 May 8;284(19):13153-64. Epub 2009 Mar 11.PMID: 19278999 [PubMed - indexed for MEDLINE]Related articles

    18.

    Global changes to the ubiquitin system in Huntington's disease.

    Bennett EJ, Shaler TA, Woodman B, Ryu KY, Zaitseva TS, Becker CH, Bates GP, Schulman H, Kopito RR.

    Nature. 2007 Aug 9;448(7154):704-8.PMID: 17687326 [PubMed - indexed for MEDLINE]Related articles

    19.

    Intersectin enhances huntingtin aggregation and neurodegeneration through activation of c-Jun-NH2-terminal kinase.

    Scappini E, Koh TW, Martin NP, O'Bryan JP.

    Hum Mol Genet. 2007 Aug 1;16(15):1862-71. Epub 2007 Jun 5.PMID: 17550941 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Nuclear accumulation of polyglutamine disease proteins and neuropathology.

    Havel LS, Li S, Li XJ.

    Mol Brain. 2009 Jul 3;2(1):21.PMID: 19575804 [PubMed - in process]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Write to the Help Desk